Capula Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35
Closed -$10.4K 1106
2025
Q4
$9.56K Sell
35
-141
-80% -$38.3K ﹤0.01% 801
2025
Q3
$47.6K Sell
176
-24
-12% -$6.53K ﹤0.01% 761
2025
Q2
$55.1K Sell
200
-216
-52% -$58.7K ﹤0.01% 579
2025
Q1
$110K Buy
+416
New +$103K ﹤0.01% 611
2021
Q4
Sell
-2,198
Closed -$425K 301
2021
Q3
$425K Buy
2,198
+744
+51% +$151K 0.01% 633
2021
Q2
$309K Buy
+1,454
New +$307K 0.01% 570
2020
Q3
Sell
-1,932
Closed -$314K 168
2020
Q2
$314K Buy
+1,932
New +$346K 0.01% 287

Other funds holding CME

Capula Management's CME Position: Q1 2026 in Review

Capula Management sold out of CME Group (CME) in Q1 2026, closing a stake of 35 shares — an estimated $10.4K sold.

Capula Management first reported a position in CME in Q2 2020 and held it in 7 quarters. The position peaked at $425K in Q3 2021. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Capula Management reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
  • Capula Management sold 35 CME Group shares in Q1 2026, an estimated $10.4K.
  • Capula Management first reported a position in CME Group in Q2 2020 and held it in 7 quarters.
  • Capula Management's CME Group position peaked at $425K in Q3 2021.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.